INHALED INSULIN : A NEWER APPROACH TO DIABETIC MANAGEMENT

In recent years, diabetes management has witnessed remarkable advancements, and one
notable breakthrough is the development of inhaled insulin. This innovation is very promising
to individuals with diabetes, particularly those who rely on insulin therapy.

What is Inhaled Insulin?

Inhaled insulin is a non-invasive alternative to traditional insulin injections. Instead of using a
needle to inject insulin, patients can now inhale it. This method utilises a small handheld
device that delivers a precise dose of insulin in the form of a fine powder into the lungs. The
insulin is then rapidly absorbed into the bloodstream, mimicking the body’s natural insulin release.

Benefits of Inhaled Insulin

● Needle-Free: Say goodbye to the daily discomfort of insulin injections. Inhaled insulin
offers a pain-free and convenient way to manage blood sugar levels.

● Rapid Onset: Inhaled insulin provides rapid relief, with its effects starting within 10-15
minutes, making it ideal for mealtime insulin delivery.

● Improved Adherence: The avoidance of needles can lead to improved adherence to
treatment plans, as the psychological barrier to insulin therapy is reduced.

● Flexible Dosing: Inhaled insulin allows for precise dosing adjustments to meet
individual insulin requirements, giving patients more control over their diabetes
management.

● Reduced Hypoglycemia: Studies have shown that inhaled insulin can lead to fewer
incidents of hypoglycemia (low blood sugar) compared to some other insulin delivery methods.

Limitations of inhaled insulin

● It may not be appropriate for individuals with certain medical conditions, such as
chronic lung diseases, like asthma or chronic obstructive pulmonary disease
(COPD).

● Inhaled insulin is currently available in a limited range of insulin types and formulations. This may not provide the same variety and flexibility as injectable
insulin, which offers a broader selection of long-acting and rapid-acting insulins.

● Precise dosing can be more challenging with inhaled insulin, and it may not be as
customizable as injectable insulin.

● Inhaled insulin can be more expensive than traditional insulin injections, which might
pose a financial burden for some individuals.

● Inhaled insulin typically has a shorter duration of action compared to some injectable
insulin options.

Side effects: Inhaled insulins also have some side effects like hypoglycemia, coughing, sore
throat, and shortening of breath.

Marketed brands: Afrezza is the only FDA approved inhaled insulin brand available now.

CONCLUSION

Inhaled insulin is revolutionising the way diabetes is managed. It provides a needle-free, convenient, and fast-acting alternative to traditional insulin injections. The development of
this technology underscores the ongoing commitment to enhancing the quality of life for
those living with diabetes.

Ubaidulla K M
Mpharm
Pharmacy Blogger
Website: https://www.itsmepharmacist.com